Pyrimidine derivatives useful in the treatment of cancer

Details for Australian Patent Application No. 2007263655 (hide)

Owner AstraZeneca AB

Inventors Thomas, Andrew Peter; Rudge, David Alan; Buttar, David; Theoclitou, MariaElena; Foote, Kevin Michael; Nowak, Thorsten

Agent Davies Collison Cave

Pub. Number AU-A-2007263655

PCT Pub. Number WO2008/001070

Priority 60/908,428 28.03.07 US; 60/818,259 30.06.06 US

Filing date 27 June 2007

Wipo publication date 3 January 2008

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/001070 Priority application(s): WO2008/001070

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263672-Method and apparatus for mounting distributed buoyancy modules on a rigid pipeline

2007263642-Apparatus for converting wave motin into mechanical energy